These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23970458)

  • 1. Gonadotrophins for idiopathic male factor subfertility.
    Attia AM; Abou-Setta AM; Al-Inany HG
    Cochrane Database Syst Rev; 2013 Aug; (8):CD005071. PubMed ID: 23970458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotrophins for idiopathic male factor subfertility.
    Attia AM; Al-Inany HG; Proctor ML
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005071. PubMed ID: 16437514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotrophins for idiopathic male factor subfertility.
    Attia AM; Al-Inany HG; Farquhar C; Proctor M
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005071. PubMed ID: 17943837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidants for male subfertility.
    Showell MG; Mackenzie-Proctor R; Brown J; Yazdani A; Stankiewicz MT; Hart RJ
    Cochrane Database Syst Rev; 2014; (12):CD007411. PubMed ID: 25504418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assisted reproductive technologies for male subfertility.
    Cissen M; Bensdorp A; Cohlen BJ; Repping S; de Bruin JP; van Wely M
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD000360. PubMed ID: 26915339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome.
    Bordewijk EM; Nahuis M; Costello MF; Van der Veen F; Tso LO; Mol BW; van Wely M
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009090. PubMed ID: 28118681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-uterine insemination for unexplained subfertility.
    Veltman-Verhulst SM; Hughes E; Ayeleke RO; Cohlen BJ
    Cochrane Database Syst Rev; 2016 Feb; 2():CD001838. PubMed ID: 26892070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidants for male subfertility.
    de Ligny W; Smits RM; Mackenzie-Proctor R; Jordan V; Fleischer K; de Bruin JP; Showell MG
    Cochrane Database Syst Rev; 2022 May; 5(5):CD007411. PubMed ID: 35506389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine insemination versus intracervical insemination in donor sperm treatment.
    Kop PA; Mochtar MH; O'Brien PA; Van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000317. PubMed ID: 29368795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome.
    Weiss NS; Nahuis M; Bayram N; Mol BW; Van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2015 Sep; (9):CD010290. PubMed ID: 26350625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced sperm selection techniques for assisted reproduction.
    McDowell S; Kroon B; Ford E; Hook Y; Glujovsky D; Yazdani A
    Cochrane Database Syst Rev; 2014 Oct; (10):CD010461. PubMed ID: 25348679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidants for male subfertility.
    Smits RM; Mackenzie-Proctor R; Yazdani A; Stankiewicz MT; Jordan V; Showell MG
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD007411. PubMed ID: 30866036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting FSH versus daily FSH for women undergoing assisted reproduction.
    Pouwer AW; Farquhar C; Kremer JA
    Cochrane Database Syst Rev; 2012 Jun; (6):CD009577. PubMed ID: 22696386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles.
    Youssef MA; Abou-Setta AM; Lam WS
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003719. PubMed ID: 27106604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection for assisted reproduction.
    Teixeira DM; Barbosa MA; Ferriani RA; Navarro PA; Raine-Fenning N; Nastri CO; Martins WP
    Cochrane Database Syst Rev; 2013 Jul; (7):CD010167. PubMed ID: 23884963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities.
    Bosteels J; Kasius J; Weyers S; Broekmans FJ; Mol BW; D'Hooghe TM
    Cochrane Database Syst Rev; 2015 Feb; (2):CD009461. PubMed ID: 25701429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteal phase support for assisted reproduction cycles.
    van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
    Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.
    Mochtar MH; Danhof NA; Ayeleke RO; Van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2017 May; 5(5):CD005070. PubMed ID: 28537052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
    D'Angelo A; Amso NN; Hassan R
    Cochrane Database Syst Rev; 2017 May; 5(5):CD002811. PubMed ID: 28535578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.